Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stem Cell Research

Free Subscription Articles published in Cancer Retrieve available abstracts of 34 articles: HTML format Text format

Single Articles

June 2018
1. SORIGUE M, Sancho JM
   The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular lymphoma.
   Cancer. 2018 Jun 7. doi: 10.1002/cncr.31565.
   PubMed     Text format    
   
   
   
2. SUREDA A, Montoto S, Dreger P, Hamadani M, et al
   Reply to The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular lymphoma.
   Cancer. 2018 Jun 7. doi: 10.1002/cncr.31564.
   PubMed     Text format    
   
   
   March 2018
3. CZERW T, Labopin M, Giebel S, Socie G, et al
   Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemi
   Cancer. 2018 Mar 30. doi: 10.1002/cncr.31354.
   PubMed     Text format     Abstract available
   
   
   
4. EL-JAWAHRI A, Fishman SR, Vanderklish J, Dizon DS, et al
   Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.
   Cancer. 2018 Mar 14. doi: 10.1002/cncr.31333.
   PubMed     Text format     Abstract available
   
   
   
5. XUAN L, Wang Y, Huang F, Jiang E, et al
   Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation.
   Cancer. 2018 Mar 6. doi: 10.1002/cncr.31295.
   PubMed     Text format     Abstract available
   
   
   February 2018
6. SESTILI S, Labopin M, Ruggeri A, Velardi A, et al
   T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
   Cancer. 2018 Feb 22. doi: 10.1002/cncr.31310.
   PubMed     Text format     Abstract available
   
   
   
7. 
   Erratum: Chang Y-J, Wang Y, Mo X-D, et al. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial. Cancer. 2017;123
   Cancer. 2018;124:868.
   PubMed     Text format    
   
   
   
8. SUREDA A, Zhang MJ, Dreger P, Carreras J, et al
   Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
   Cancer. 2018 Feb 9. doi: 10.1002/cncr.31264.
   PubMed     Text format     Abstract available
   
   
   January 2018
9. RUGGERI A, Labopin M, Bacigalupo A, Gulbas Z, et al
   Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.
   Cancer. 2018 Jan 23. doi: 10.1002/cncr.31228.
   PubMed     Text format     Abstract available
   
   
   November 2017
10. RUUTU T, Nihtinen A, Niittyvuopio R, Juvonen E, et al
    A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31100.
    PubMed     Text format     Abstract available
    
    
    September 2017
11. SCHEICH S, Lindner S, Koenig R, Reinheimer C, et al
    Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
    Cancer. 2017 Sep 28. doi: 10.1002/cncr.31045.
    PubMed     Text format     Abstract available
    
    
    August 2017
12. PRINTZ C
    First person: Rainer Storb, MD: The pioneer in bone marrow transplantation continues to push the innovation envelope while inspiring a new generation of researchers.
    Cancer. 2017;123:2793.
    PubMed     Text format    
    
    
    June 2017
13. HUI L, von Keudell G, Wang R, Zeidan AM, et al
    Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30818.
    PubMed     Text format     Abstract available
    
    
    May 2017
14. RAJAGOPAL R, Miles GCP, Kotecha RS
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for pediatric primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30768.
    PubMed     Text format    
    
    
    
15. VELTRI LW, Milton DR, Delgado R, Shah N, et al
    Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
    Cancer. 2017 May 17. doi: 10.1002/cncr.30770.
    PubMed     Text format     Abstract available
    
    
    
16. SCHRIBER JR, Hari PN, Ahn KW, Fei M, et al
    Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
    Cancer. 2017 May 4. doi: 10.1002/cncr.30747.
    PubMed     Text format     Abstract available
    
    
    April 2017
17. ULLRICH CK, Rodday AM, Bingen KM, Kupst MJ, et al
    Three sides to a story: Child, parent, and nurse perspectives on the child's experience during hematopoietic stem cell transplantation.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30723.
    PubMed     Text format     Abstract available
    
    
    
18. BATTIPAGLIA G, Ruggeri A, Massoud R, El Cheikh J, et al
    Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30680.
    PubMed     Text format     Abstract available
    
    
    
19. NICOLINI FE, Basak GW, Kim DW, Olavarria E, et al
    Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30558.
    PubMed     Text format     Abstract available
    
    
    
20. DEFILIPP Z, Li S, El-Jawahri A, Armand P, et al
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30695.
    PubMed     Text format     Abstract available
    
    
    March 2017
21. YUCEL OK, Saliba RM, Rondon G, Ahmed S, et al
    Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogenic stem cell transplantation using reduced intensity conditioning.
    Cancer. 2017 Mar 21. doi: 10.1002/cncr.30632.
    PubMed     Text format     Abstract available
    
    
    
22. CHANG YJ, Wang Y, Mo XD, Zhang XH, et al
    Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial.
    Cancer. 2017 Mar 16. doi: 10.1002/cncr.30540.
    PubMed     Text format     Abstract available
    
    
    January 2017
23. BEKAII-SAAB T, El-Rayes B
    Identifying and targeting cancer stem cells in the treatment of gastric cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30538.
    PubMed     Text format     Abstract available
    
    
    
24. EL-JAWAHRI A, Chen YB, Brazauskas R, He N, et al
    Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    Cancer. 2017 Jan 19. doi: 10.1002/cncr.30546.
    PubMed     Text format     Abstract available
    
    
    December 2016
25. MILGROM SA, Jauhari S, Plastaras JP, Nieto Y, et al
    A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Cancer. 2016 Dec 16. doi: 10.1002/cncr.30482.
    PubMed     Text format     Abstract available
    
    
    
26. GORIN NC, Labopin M, Czerw T, Pabst T, et al
    Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the Eu
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30400.
    PubMed     Text format     Abstract available
    
    
    October 2016
27. 
    Erratum: Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F, Martini M, De Maria R and Larocca LM. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer. 2011;117:162-17
    Cancer. 2016;122:3090.
    PubMed     Text format    
    
    
    September 2016
28. MIAN I, Milton DR, Shah N, Nieto Y, et al
    Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.
    Cancer. 2016 Sep 28. doi: 10.1002/cncr.30366.
    PubMed     Text format     Abstract available
    
    
    July 2016
29. GABALLA S, Ge I, El Fakih R, Brammer JE, et al
    Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
    Cancer. 2016 Jul 12. doi: 10.1002/cncr.30180.
    PubMed     Text format     Abstract available
    
    
    June 2016
30. DEOL A, Sengsayadeth S, Ahn KW, Wang HL, et al
    Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
    Cancer. 2016 Jun 17. doi: 10.1002/cncr.30140.
    PubMed     Text format     Abstract available
    
    
    
31. GIEBEL S, Czyz A, Ottmann O, Baron F, et al
    Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the acute leukemia working party of
    Cancer. 2016 Jun 16. doi: 10.1002/cncr.30130.
    PubMed     Text format     Abstract available
    
    
    May 2016
32. FATHI AT, DeAngelo DJ, Stevenson KE, Kolitz JE, et al
    Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
    Cancer. 2016 May 12. doi: 10.1002/cncr.30037.
    PubMed     Text format     Abstract available
    
    
    March 2016
33. TU SM, Bilen MA, Hess KR, Broaddus RR, et al
    Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer.
    Cancer. 2016 Mar 28. doi: 10.1002/cncr.29996.
    PubMed     Text format     Abstract available
    
    
    February 2016
34. DEPERALTA DK, Wei L, Ghoshal S, Schmidt B, et al
    Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.
    Cancer. 2016 Feb 23. doi: 10.1002/cncr.29912.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: